Michael Mauro Discusses Therapy-Free CML Remission
17 vistas
• 07/29/23
0
0
Empotrar
administrator
Suscriptores
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses stopping chronic myeloid leukemia (CML) treatment for therapy-free remission.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios